Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Ares Management in conjunction with an investment in Gladsheim Fastigheter AB
Mandate

Vinge advises Ares Management in conjunction with an investment in Gladsheim Fastigheter AB

August 13, 2021 Employment and Benefits Corporate Tax M&A Banking and Finance

Vinge advises Ares Management in conjunction with an investment of up to SEK 2,000,000,000 in Gladsheim Fastigheter AB. Ares Management is a leading global alternative investment manager offering clients complementary primary and secondary investment solutions across the credit, private equity, real estate and infrastructure asset classes.

Vinge’s team consisted of, among others, Assur Badur, Frida Ställborn and Karolina Cohrs (real estate), Matthias Pannier and Isabelle Jengsell (M&A), Elin Broman (employment), Ludvig Wettergren and Karl-Gustaw Tobola (financing) and Victor Ericsson (tax).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026